vs

Side-by-side financial comparison of Corteva (CTVA) and State Street Corporation (STT). Click either name above to swap in a different company.

Corteva is the larger business by last-quarter revenue ($3.9B vs $3.7B, roughly 1.1× State Street Corporation). State Street Corporation runs the higher net margin — 20.4% vs -14.1%, a 34.5% gap on every dollar of revenue. On growth, State Street Corporation posted the faster year-over-year revenue change (7.5% vs -1.7%). State Street Corporation produced more free cash flow last quarter ($9.8B vs $4.2B). Over the past eight quarters, State Street Corporation's revenue compounded faster (8.1% CAGR vs -6.7%).

Corteva, Inc. is an American company devoted to products for seeds and crop protection, including herbicides, insecticides, fungicides, and biologicals that are sold in 110 countries. The company's name combines "cor" with "teva". It is headquartered in Indianapolis, Indiana. Corteva sells a large portion of their seeds under the Pioneer Hi-Bred International brand.

State Street Corporation is an American multinational financial services and bank holding company headquartered at One Congress Street in Boston. It is the second-oldest continuously operating U.S. bank, tracing its roots to Union Bank, chartered in 1792. As of the third quarter of 2025, State Street is one of the world's largest asset managers and custodians, with approximately US$5.4 trillion in assets under management and US$51.7 trillion under custody and administration.

CTVA vs STT — Head-to-Head

Bigger by revenue
CTVA
CTVA
1.1× larger
CTVA
$3.9B
$3.7B
STT
Growing faster (revenue YoY)
STT
STT
+9.2% gap
STT
7.5%
-1.7%
CTVA
Higher net margin
STT
STT
34.5% more per $
STT
20.4%
-14.1%
CTVA
More free cash flow
STT
STT
$5.6B more FCF
STT
$9.8B
$4.2B
CTVA
Faster 2-yr revenue CAGR
STT
STT
Annualised
STT
8.1%
-6.7%
CTVA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTVA
CTVA
STT
STT
Revenue
$3.9B
$3.7B
Net Profit
$-552.0M
$747.0M
Gross Margin
42.4%
Operating Margin
-13.6%
25.0%
Net Margin
-14.1%
20.4%
Revenue YoY
-1.7%
7.5%
Net Profit YoY
-1246.3%
-4.6%
EPS (diluted)
$-0.80
$2.41

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTVA
CTVA
STT
STT
Q4 25
$3.9B
$3.7B
Q3 25
$2.6B
$3.5B
Q2 25
$6.5B
$3.4B
Q1 25
$4.4B
$3.3B
Q4 24
$4.0B
$3.4B
Q3 24
$2.3B
$3.3B
Q2 24
$6.1B
$3.2B
Q1 24
$4.5B
$3.1B
Net Profit
CTVA
CTVA
STT
STT
Q4 25
$-552.0M
$747.0M
Q3 25
$-320.0M
$861.0M
Q2 25
$1.3B
$693.0M
Q1 25
$652.0M
$644.0M
Q4 24
$-41.0M
$783.0M
Q3 24
$-524.0M
$730.0M
Q2 24
$1.1B
$711.0M
Q1 24
$419.0M
$463.0M
Gross Margin
CTVA
CTVA
STT
STT
Q4 25
42.4%
Q3 25
37.2%
Q2 25
54.6%
Q1 25
47.0%
Q4 24
37.3%
Q3 24
32.7%
Q2 24
52.3%
Q1 24
43.2%
Operating Margin
CTVA
CTVA
STT
STT
Q4 25
-13.6%
25.0%
Q3 25
-14.1%
31.1%
Q2 25
27.9%
25.8%
Q1 25
17.7%
25.0%
Q4 24
2.2%
28.1%
Q3 24
-27.2%
28.4%
Q2 24
21.9%
28.6%
Q1 24
10.7%
19.1%
Net Margin
CTVA
CTVA
STT
STT
Q4 25
-14.1%
20.4%
Q3 25
-12.2%
24.3%
Q2 25
20.4%
20.1%
Q1 25
14.8%
19.6%
Q4 24
-1.0%
22.9%
Q3 24
-22.5%
22.4%
Q2 24
17.2%
22.3%
Q1 24
9.3%
14.8%
EPS (diluted)
CTVA
CTVA
STT
STT
Q4 25
$-0.80
$2.41
Q3 25
$-0.47
$2.78
Q2 25
$1.92
$2.17
Q1 25
$0.95
$2.04
Q4 24
$-0.05
$2.43
Q3 24
$-0.76
$2.26
Q2 24
$1.51
$2.15
Q1 24
$0.60
$1.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTVA
CTVA
STT
STT
Cash + ST InvestmentsLiquidity on hand
$4.5B
Total DebtLower is stronger
$1.7B
Stockholders' EquityBook value
$24.1B
$27.8B
Total Assets
$42.8B
$366.0B
Debt / EquityLower = less leverage
0.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTVA
CTVA
STT
STT
Q4 25
$4.5B
Q3 25
$2.6B
Q2 25
$2.1B
Q1 25
$2.0B
Q4 24
$3.2B
Q3 24
$2.5B
Q2 24
$2.0B
Q1 24
$1.7B
Total Debt
CTVA
CTVA
STT
STT
Q4 25
$1.7B
Q3 25
$1.7B
Q2 25
$1.7B
Q1 25
$1.8B
Q4 24
$2.0B
Q3 24
$2.0B
Q2 24
$2.5B
Q1 24
$2.5B
Stockholders' Equity
CTVA
CTVA
STT
STT
Q4 25
$24.1B
$27.8B
Q3 25
$25.2B
$27.6B
Q2 25
$25.9B
$27.3B
Q1 25
$24.3B
$26.7B
Q4 24
$23.8B
$25.3B
Q3 24
$24.7B
$25.8B
Q2 24
$25.2B
$24.8B
Q1 24
$24.8B
$24.4B
Total Assets
CTVA
CTVA
STT
STT
Q4 25
$42.8B
$366.0B
Q3 25
$42.2B
$371.1B
Q2 25
$41.8B
$376.7B
Q1 25
$42.1B
$372.7B
Q4 24
$40.8B
$353.2B
Q3 24
$41.9B
$338.5B
Q2 24
$41.5B
$325.6B
Q1 24
$43.6B
$338.0B
Debt / Equity
CTVA
CTVA
STT
STT
Q4 25
0.07×
Q3 25
0.07×
Q2 25
0.07×
Q1 25
0.07×
Q4 24
0.08×
Q3 24
0.08×
Q2 24
0.10×
Q1 24
0.10×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTVA
CTVA
STT
STT
Operating Cash FlowLast quarter
$4.4B
$10.0B
Free Cash FlowOCF − Capex
$4.2B
$9.8B
FCF MarginFCF / Revenue
106.2%
266.6%
Capex IntensityCapex / Revenue
5.7%
7.3%
Cash ConversionOCF / Net Profit
13.44×
TTM Free Cash FlowTrailing 4 quarters
$2.8B
$10.8B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTVA
CTVA
STT
STT
Q4 25
$4.4B
$10.0B
Q3 25
$193.0M
$7.9B
Q2 25
$947.0M
$-8.4B
Q1 25
$-2.1B
$2.4B
Q4 24
$4.2B
$-7.4B
Q3 24
$130.0M
$2.7B
Q2 24
$451.0M
$-7.6B
Q1 24
$-2.6B
$-844.0M
Free Cash Flow
CTVA
CTVA
STT
STT
Q4 25
$4.2B
$9.8B
Q3 25
$36.0M
$7.7B
Q2 25
$829.0M
$-8.8B
Q1 25
$-2.2B
$2.2B
Q4 24
$4.0B
$-7.7B
Q3 24
$-24.0M
$2.5B
Q2 24
$337.0M
$-7.9B
Q1 24
$-2.8B
$-1.1B
FCF Margin
CTVA
CTVA
STT
STT
Q4 25
106.2%
266.6%
Q3 25
1.4%
216.0%
Q2 25
12.8%
-254.1%
Q1 25
-49.9%
66.1%
Q4 24
100.4%
-225.1%
Q3 24
-1.0%
75.9%
Q2 24
5.5%
-246.2%
Q1 24
-61.4%
-34.2%
Capex Intensity
CTVA
CTVA
STT
STT
Q4 25
5.7%
7.3%
Q3 25
6.0%
6.9%
Q2 25
1.8%
9.3%
Q1 25
2.1%
6.9%
Q4 24
4.6%
7.3%
Q3 24
6.6%
7.2%
Q2 24
1.9%
6.7%
Q1 24
3.3%
7.3%
Cash Conversion
CTVA
CTVA
STT
STT
Q4 25
13.44×
Q3 25
9.18×
Q2 25
0.72×
-12.18×
Q1 25
-3.23×
3.72×
Q4 24
-9.49×
Q3 24
3.71×
Q2 24
0.43×
-10.75×
Q1 24
-6.23×
-1.82×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTVA
CTVA

Corn$1.4B35%
Herbicides$1.1B27%
Insecticides$488.0M12%
Fungicides$272.0M7%
Biologicals$191.0M5%
Soybean$164.0M4%
Other$160.0M4%
Otheroilseeds$94.0M2%

STT
STT

Other$2.2B59%
Investment Management$729.0M20%
Management Services$662.0M18%
Other Fee Revenue$56.0M2%
Securities Financing Services$54.0M1%

Related Comparisons